2Ishigaml M,Feger DW,Granholm NA,et al.ApoE inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to Gl phase[J].JBiol Chem,1998,273(32):20156-20
3Maor I,Aviram M.Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester[J].J Lipid Res,1994,35:803-819.
4Krwth HS,Skarlatos SI,Gaynor PM,et al.Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux[J].J Biol Chem,1994,269(39):24511-24518.
5Shore VG,Shore B.Heterogeneity of human plasma very low density lipoproteins,separation of species differing in protein components[J].Biochemistry,1973,12(3):502-507.
6Piedrahita JA,Zhang SH,Hagaman JR,et al.Generation of mice carring a mutant apoliprotein E gene inactivated by gene targeting in embryomic stem cells[J].Proc Natl Acad Sci USA,1992,89:4471-4475.
7Nakashima Y,Plump AS,Raines EW,et al.ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree[J].Arterioscler Thromb,1994,14:133-140.
9Hasty AH,Linton MF,Brandt SJ,et al.Retroviral gene therapy in apoE-deficient mice aopE expression in the artery wall reduces early foam cell lesion formation[J].Circulation,1999,99(19):2571-2576.
10Cader AA,Steinberg FM,Mazzone T,et al.Mechanism of enhanced macrophage apoE secretion by oxidized LDL[J].J Lipid Res,1997,38:981-991.
二级参考文献6
1Rosenson RS,Tangney CC.Antiatherothrombotic properties of statins:implications for cardio-vascular event reduction[].The Journal of The American Medical Association.1998
2Niwa S,Totsuka T,Hayashi S.Inhibitory effect of Fluvastatin on the expression of adhesion molecules in human monocyte cell line[].International Journal of Immunopharmacology.1996
3Tsao PS,Cooke JP.Endothelial alteration in hypercholesterolemia:more than simply vasodilator dysfunction[].J Cardiovasc Pharmacol (Suppl )∶.
4Laufs U,La Fata V,Liao JK,et al.Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors[].Circulation.1998
5Tsao PS,Buitrago R,Reaven G,et al.Effect of experimental diabetes on monocyte endothelial inter-actions[].Arteriosclerosis and Thrombosis.1998
6Taso PS,Wang BY,Cooke JP,et al.Nitric oxide regulates the expression of monocyte chemotactic protein-1[].Circulation.1997
5Breslow JL.Mouse models of Atherisclerosis[J].Science,1996,272(5262):685-688.
6Plump AS,Smith JD,Hayek T,et al.Severe hypercholesterolemia and atheroslerosis in apolipoprotein E-deficient mice created by homologous recombination in ES Cells[J].Cell,1992,71(2):343-353.
7Sunny HZ,Reddick RL,Piedrahita JA,et al.Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E[J].Science,1992,258(10):468-471.
8Winnik S,Lohmann C,Siciliani G,et al.Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis-implications for cardiovascular safety[J].Int J Cardiol,2013,168(3):2453-2461.
